Direct effect of GLP-1 infusion on endogenous glucose production in humans

被引：0
|
作者：
M. Seghieri
E. Rebelos
A. Gastaldelli
B. D. Astiarraga
A. Casolaro
E. Barsotti
A. Pocai
M. Nauck
E. Muscelli
E. Ferrannini
机构：
[1] University of Pisa School of Medicine,Department of Internal Medicine
[2] C.N.R. Institute of Clinical Physiology,undefined
[3] Merck Sharp & Dohme,undefined
[4] Diabeteszentrum Bad Lauterberg,undefined
来源：
Diabetologia | 2013年 / 56卷
关键词：
Endogenous glucose production; GLP-1; Liver glucose output; Pancreatic clamp;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：156 / 161
页数：5
相关论文
共 50 条
  • [21] Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes
    Salehi, Marzieh
    Aulinger, Benedict
    Prigeon, Ronald L.
    D'Alessio, David A.
    DIABETES, 2010, 59 (06) : 1330 - 1337
  • [22] Confirmation That Endogenous GLP-1 Is A Human Enterogastrone
    Goetze, Oliver
    Fox, Mark
    Kaufman, Elad
    Forras-Kaufman, Zsofia
    Treier, Reto
    Fried, Michael
    Boesiger, Peter
    Schwizer, Werner
    SWISS MEDICAL WEEKLY, 2009, 139 (35-36) : 6S - 6S
  • [23] The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem
    Alvarez, E
    Martínez, MD
    Roncero, I
    Chowen, JA
    García-Cuartero, B
    Gispert, JD
    Sanz, C
    Vázquez, P
    Maldonado, A
    de Cáceres, J
    Desco, M
    Pozo, MA
    Blázquez, E
    JOURNAL OF NEUROCHEMISTRY, 2005, 92 (04) : 798 - 806
  • [24] The Renal Extraction and the Natriuretic Action of GLP-1 in Humans Depend on Interaction With the GLP-1 Receptor
    Asmar, Ali
    Cramon, Per K.
    Asmar, Meena
    Simonsen, Lene
    Sorensen, Charlotte M.
    Madsbad, Sten
    Hartmann, Bolette
    Holst, Jens J.
    Hovind, Peter
    Jensen, Boye L.
    Bulow, Jens
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (01): : E11 - E19
  • [25] The Effect of Ingested Glucose Dose on the Suppression of Endogenous Glucose Production in Humans
    Kowalski, Greg M.
    Moore, Samantha M.
    Hamley, Steven
    Selathurai, Ahrathy
    Bruce, Clinton R.
    DIABETES, 2017, 66 (09) : 2400 - 2406
  • [26] GLP-1 and GIP contribute nearly equally to the incretin effect in humans
    Vilsboll, T
    Krarup, T
    Madsbad, S
    Holst, J
    DIABETES, 2003, 52 : A325 - A325
  • [27] Resistant Starch and Pullulan Reduce Postprandial Glucose, Insulin, and GLP-1, but Have No Effect on Satiety in Healthy Humans
    Klosterbuer, Abby S.
    Thomas, William
    Slavin, Joanne L.
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2012, 60 (48) : 11928 - 11934
  • [28] GLP-1 Is a Coronary Artery Vasodilator in Humans
    Clarke, Sophie J.
    Giblett, Joel P.
    Yang, Lucy L.
    Hubsch, Annette
    Zhao, Tian
    Aetesam-ur-Rahman, Muhammad
    West, Nick E. J.
    O'Sullivan, Michael
    Figg, Nichola
    Bennett, Martin
    Albrechtsen, Nicolai J. Wewer
    Deacon, Carolyn F.
    Cheriyan, Joseph
    Hoole, Stephen P.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (22):
  • [29] GLP-1 differentially affects blood-brain glucose transfer and metabolism in humans
    Egefjord, L.
    Gejl, M.
    Bibby, B.
    Moller, N.
    Brock, B.
    Rungby, J.
    Gjedde, A.
    DIABETOLOGIA, 2011, 54 : S63 - S63
  • [30] Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
    Koska, Juraj
    Sands, Michelle
    Burciu, Camelia
    D'Souza, Karen M.
    Raravikar, Kalyani
    Liu, James
    Truran, Seth
    Franco, Daniel A.
    Schwartz, Eric A.
    Schwenke, Dawn C.
    D'Alessio, David
    Migrino, Raymond Q.
    Reaven, Peter D.
    DIABETES, 2015, 64 (07) : 2624 - 2635
12345